S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K/AKT pathway
Author(s) -
Yan Sun,
Huan Zhang,
Junpeng Meng,
Feng Guo,
Dianyun Ren,
Heshui Wu,
Xin Jin
Publication year - 2022
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2022.111194
Subject(s) - palmitoylation , pten , protein kinase b , sorafenib , cancer research , pi3k/akt/mtor pathway , chemistry , phosphorylation , biology , signal transduction , microbiology and biotechnology , biochemistry , hepatocellular carcinoma , cysteine , enzyme
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom